跳至主要内容
临床试验/NCT03198351
NCT03198351已完成不适用

Teriflunomide Pregnancy Outcome Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project

Sanofi2 个研究点 分布在 2 个国家目标入组 220 人开始时间: 2013年4月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Sanofi
入组人数
220
试验地点
2
主要终点
Rate of major structural defects in live born infants

研究概览

简要总结

Primary Objective:

To evaluate any potential increase in the risk of major birth defects, in the first year of life, in teriflunomide-exposed pregnancies.

Secondary Objective:

To evaluate the potential effect of teriflunomide-exposure on other adverse pregnancy outcomes including any potential pattern of minor birth defects, spontaneous abortion, stillbirth, preterm delivery, small for gestational age at birth and at 1 year follow-up.

详细描述

The total study duration per participant is approximately up to 2 years.

  • This is a prospective, observational study (no intervention), ie, patient registry.
  • The statistical analysis for the cohort study describe baseline characteristics in all three cohorts, and then will compare pregnancy outcomes in cohort 1 to cohort 2 and secondarily to cohort 3.
  • For the "registry" group, without comparisons, only descriptive statistics of pregnancy outcomes will be summarized.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Cohort I

Pregnant women with a confirmed diagnosis of multiple sclerosis (MS) and teriflunomide exposure during the current pregnancy

干预措施: Teriflunomide (HMR1726) (Drug)

结局指标

主要结局

Rate of major structural defects in live born infants

时间窗: Up to the infant's first year birthday

次要结局

  • Proportion of major structural defects in all pregnancies(up to 1 year of age in infant)
  • Rate of preterm delivery(live birth prior to 37 weeks gestation)
  • Proportion of infants who are small for gestational age (less than or equal to the 10th percentile for gestational age and sex) on weight, length, or head circumference(at birth)
  • Specific pattern of 3 or more minor structural defects in live born infants receiving the exam(up to one year after birth)
  • Rate of spontaneous abortion(date of conception to 20 weeks gestation)
  • Proportion of infants less than or equal to the 10th percentile for sex and age on weight, length, or head circumference at 1 year postnatal evaluation(1 year)

研究者

发起方
Sanofi
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验